Alessandro Rossi

Via Manzoni, 56, Rozzano
Milan, 20089, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

An inflammatory fingerprint in mild cognitively impaired patients is reversed by physical and cognitive training.

An inflammatory fingerprint in mild cognitively impaired patients is reversed by physical and cognitive training.

Journal: Brain, behavior, & immunity - health
Published: March 20, 2025

Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model.

Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model.

Journal: ACS nano
Published: March 19, 2019

Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.

Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.

Journal: Journal of Alzheimer's disease : JAD
Published: March 12, 2017

HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.

HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.

Journal: Scientific reports
Published: February 22, 2017

The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.

The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.

Journal: Journal of Alzheimer's disease : JAD
Published: July 10, 2016

Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17.

Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17.

Journal: Scientific reports
Published: March 30, 2016

Tackling amyloidogenesis in Alzheimer's disease with A2V variants of Amyloid-β.

Tackling amyloidogenesis in Alzheimer's disease with A2V variants of Amyloid-β.

Journal: Scientific reports
Published: October 27, 2015

Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation.

Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation.

Journal: The Journal of biological chemistry
Published: September 02, 2015

The new β amyloid-derived peptide Aβ1-6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity.

The new β amyloid-derived peptide Aβ1-6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity.

Journal: Neurobiology of disease
Published: May 27, 2015

The peculiar role of the A2V mutation in amyloid-β (Aβ) 1-42 molecular assembly.

The peculiar role of the A2V mutation in amyloid-β (Aβ) 1-42 molecular assembly.

Journal: The Journal of biological chemistry
Published: July 20, 2014

Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.

Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.

Journal: Rivista di psichiatria
Published: February 28, 2014

Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity.

Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity.

Journal: Neurobiology of disease
Published: December 24, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026